Pressure BioSciences (OTCQB: PBIO) has scheduled a teleconference for today to release its third-quarter 2020 financial results and announce key business updates. PBIO is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries. The call, scheduled for today, Nov. … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Conference Call to Discuss Q3 Finances, Business Update”
Life sciences technology innovator Pressure BioSciences (OTCQB: PBIO) has increased its IP stable to 26 patents worldwide with the announcement of its first U.S. patent for its revolutionary Ultra Shear Technology(TM) (“UST”) Platform The patent (US 10,823,159) – entitled “System for High Pressure, High Shear Processing of Fluids” – will be the framework of the … Continue reading “Pressure BioSciences’ (PBIO) First Issued U.S. Patent for Its Novel UST Platform Advances the Company Toward 2021 Product Delivery, Significant Acceleration of Revenue, and Profitability”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of the first U.S. patent for its revolutionary Ultra Shear Technology(TM) (UST(TM)) platform. The patent, entitled “System for High Pressure, High Shear Processing of Fluids,” … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Awarded First US Patent for Revolutionary UST(TM) Platform”
Pressure BioSciences (OTCQB: PBIO), a developer of innovative solutions for the worldwide life science and other industries, recently achieved another milestone as it nears initial production of commercial systems expected to revolutionize the nanoemulsification process for a wide variety of sectors. The company’s proprietary, next-generation Ultra Shear Technology-based BaroShear K45 System is designed to create … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Path to Commercialization Targets Multibillion Hemp-Derived CBD Market”
Pressure BioSciences has been making a name for itself as a leader in the development and sale of proprietary intense-pressure delivery systems to the worldwide life sciences field PBIO is developing a novel high pressure platform called Ultra-Shear Technology (“UST”) that processes oil-based solutions into water-soluble nanoemulsions that will allow the molecules inside the oil … Continue reading “Pressure BioSciences (PBIO) Achieves Critical Milestone in Commercial Rollout of Revolutionary Nanoemulsification System”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, has reached what it calls as a critical milestone. The company announced the lock-in of final design specifications for the commercial production model of its proprietary, … Continue reading “NetworkNewsBreaks – Pressure BioSciences (PBIO) Locks In Final System Design, Begins Production of Alpha Unit”
Pressure BioSciences (OTCQB: PBIO) recently announced its receipt of a pivotal U.S. patent for “Sample Preparation Devices and Methods,” which expands its already significant intellectual property (“IP”) portfolio. This award increases Pressure BioSciences’ IP ownership to include 25 issued patents protecting its unique pressure-cycling technology (“PCT”) systems. The newly patented PCT MicroPestle (“MP”) is a … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Awarded Key Patent for Critical Addition to Instruments, Consumables Product Line”
Pressure BioSciences develops and sells pressure-based instruments and consumables to the global life sciences, food and beverage, and other large research markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the … Continue reading “Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, today announced the award of a key U.S. patent entitled “Sample Preparation Devices and Methods.” According to the update, the new patent (U.S. 10,710,082) brings the company’s … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Achieves Critical Milestone Through Award of Key Patent”
Pressure BioSciences (OTCQB: PBIO) on Tuesday announced that it will host a teleconference to discuss its first quarter 2020 financial results and to provide a business update, including the Company’s progress made in the development of its Ultra Shear Technology(TM) (“UST(TM)) Platform and in the pending merger of PBI, Cannaworx, and SkinScience Labs. The call … Continue reading “NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) to Host Teleconference to Discuss Q1 2020 Results and Provide Business Update”
